Once upon a time a big success for Antisense would have been significant for Opthea - they used to hold a larger fraction of the company, and the two companies had vaguely similar market caps. But now ANP could triple in value and that'd be worth barely $1 million to Opthea - of no real consequence for a company with $30 million in cash and a market cap approaching $1 billion.
More interesting would be if Opthea could now look at some of the other IP assets it inherited from its life as Circadian...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
60.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $738.7M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| OPT (ASX) Chart |
Day chart unavailable